Paul N. Harris

546 total citations
11 papers, 172 citations indexed

About

Paul N. Harris is a scholar working on Molecular Biology, Organic Chemistry and Small Animals. According to data from OpenAlex, Paul N. Harris has authored 11 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Small Animals. Recurrent topics in Paul N. Harris's work include Synthesis and Biological Evaluation (2 papers), Fungal Plant Pathogen Control (1 paper) and Ferrocene Chemistry and Applications (1 paper). Paul N. Harris is often cited by papers focused on Synthesis and Biological Evaluation (2 papers), Fungal Plant Pathogen Control (1 paper) and Ferrocene Chemistry and Applications (1 paper). Paul N. Harris collaborates with scholars based in United States. Paul N. Harris's co-authors include Robert C. Anderson, Max C. McCowen, Martin Sweeney, Richard E. Holmes, Robert H. Williams, Gerald A. Poore, Koert Gerzon, Robert D. Dillard, W. R. Gibson and G. H. A. Clowes and has published in prestigious journals such as Diabetes, Journal of Pharmacology and Experimental Therapeutics and Toxicology and Applied Pharmacology.

In The Last Decade

Paul N. Harris

11 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul N. Harris United States 6 96 36 21 20 16 11 172
A. J. Baxi India 9 54 0.6× 32 0.9× 6 0.3× 41 2.0× 52 3.3× 39 317
Kurt Schreier Germany 9 99 1.0× 12 0.3× 5 0.2× 8 0.4× 11 0.7× 56 379
R. M. B. MacKenna United Kingdom 9 59 0.6× 15 0.4× 5 0.2× 4 0.2× 7 0.4× 19 257
P. R. Peacock United Kingdom 7 117 1.2× 41 1.1× 35 1.7× 13 0.7× 11 0.7× 18 224
Taizo Matsukawa Japan 9 55 0.6× 9 0.3× 9 0.4× 21 1.1× 79 4.9× 43 197
K. F. Klippel Germany 9 101 1.1× 20 0.6× 5 0.2× 29 1.4× 10 0.6× 32 359
Fujiho Tanaka Japan 9 78 0.8× 57 1.6× 3 0.1× 89 4.5× 12 0.8× 21 275
M. McMillan United Kingdom 7 105 1.1× 17 0.5× 4 0.2× 48 2.4× 8 0.5× 7 289
Akhil Bhargava Germany 12 88 0.9× 24 0.7× 2 0.1× 10 0.5× 19 1.2× 20 277
G Rabitzsch Germany 8 53 0.6× 4 0.1× 5 0.2× 10 0.5× 8 0.5× 23 241

Countries citing papers authored by Paul N. Harris

Since Specialization
Citations

This map shows the geographic impact of Paul N. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul N. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul N. Harris more than expected).

Fields of papers citing papers by Paul N. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul N. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul N. Harris. The network helps show where Paul N. Harris may publish in the future.

Co-authorship network of co-authors of Paul N. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Paul N. Harris. A scholar is included among the top collaborators of Paul N. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul N. Harris. Paul N. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Harris, Paul N., W. R. Gibson, & Robert D. Dillard. (1972). Oncogenicity of 1-(4-chlorophenyl)-1-phenyl-2-propynyl carbamate for rats. Toxicology and Applied Pharmacology. 21(3). 414–418. 4 indexed citations
2.
Sweeney, Martin, Koert Gerzon, Paul N. Harris, et al.. (1972). Experimental antitumor activity and preclinical toxicology of mycophenolic acid.. PubMed. 32(9). 1795–802. 50 indexed citations
3.
Harris, Paul N., W. R. Gibson, & Robert D. Dillard. (1970). The oncogenicity of two 1,1-diaryl-2-propynyl N-cycloalkylcarbamates.. PubMed. 30(12). 2952–4. 8 indexed citations
4.
Harris, Paul N., et al.. (1970). Development of hepatic tumors in rats following ingestion of Senecio longilobus.. PubMed. 30(12). 2881–6. 42 indexed citations
5.
Johnson, Irving S., et al.. (1966). Preclinical studies with vinglycinate, one of a series of chemically derived analogs of vinblastine.. PubMed. 26(12). 2431–6. 2 indexed citations
6.
Rose, Charles L., et al.. (1959). SOME PHARMACOLOGICAL ACTIONS OF SUPININE AND LASIOCARPINE. Journal of Pharmacology and Experimental Therapeutics. 126(2). 179–184. 3 indexed citations
7.
Anderson, Robert C., et al.. (1957). PHARMACOLOGIC ACTION OF HYPOGLYCIN A AND B. Journal of Pharmacology and Experimental Therapeutics. 121(3). 272–285. 37 indexed citations
8.
Anderson, Robert C., H Worth, & Paul N. Harris. (1957). Toxicological Studies on Carbutamide. Diabetes. 6(1). 2–7. 5 indexed citations
9.
Anderson, Robert C., et al.. (1955). Further toxicological studies with ilotycin® (Erythromycin, Lilly). Journal of the American Pharmaceutical Association (Scientific ed ). 44(4). 199–204. 3 indexed citations
10.
Anderson, Robert C., et al.. (1952). The Toxicity and Distribution of ‘Ilotycin’†. Journal of the American Pharmaceutical Association (Scientific ed ). 41(10). 555–559. 13 indexed citations
11.
Harris, Paul N. & G. H. A. Clowes. (1952). Observations on carcinogenesis by 4-dimethylaminoazobenzene.. PubMed. 12(7). 471–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026